189 related articles for article (PubMed ID: 31870123)
21. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.
Soo RA; Lim HL; Wang LZ; Lee HS; Millward MJ; Tok LT; Lee SC; Lehnert M; Goh BC
Cancer Chemother Pharmacol; 2003 Aug; 52(2):153-8. PubMed ID: 12750842
[TBL] [Abstract][Full Text] [Related]
23. Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer.
Micha JP; Goldstein BH; Mattison JA; Bader K; Graham C; Rettenmaier MA; Brown JV; Markman M
Gynecol Oncol; 2005 Jan; 96(1):132-5. PubMed ID: 15589591
[TBL] [Abstract][Full Text] [Related]
24. Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition.
Zheng XY; Li LJ; Li W; Jiang PF; Shen HQ; Chen YH; Chen X
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2309-15. PubMed ID: 26335535
[TBL] [Abstract][Full Text] [Related]
25. The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells.
Chen M; He M; Song Y; Chen L; Xiao P; Wan X; Dai F; Shen P
Int J Mol Med; 2014 Jul; 34(1):276-82. PubMed ID: 24804820
[TBL] [Abstract][Full Text] [Related]
26. New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study.
Illiano A; Barletta E; De Marino V; Battiloro C; Barzelloni M; Scognamiglio F; Rossi N; Zampa G; De Bellis M; Gridelli C
Anticancer Res; 2000; 20(5C):3999-4003. PubMed ID: 11268491
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
Zhang HQ; Fang N; Liu XM; Xiong SP; Liao YQ; Jin WJ; Song RF; Wan YY
Asian Pac J Cancer Prev; 2015; 16(9):3907-12. PubMed ID: 25987058
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
de Lima Lopes G; Chiappori A; Simon G; Haura E; Sullivan D; Antonia S; Langevin M; Lush R; Rocha-Lima CM
Cancer; 2007 Apr; 109(7):1413-9. PubMed ID: 17326096
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer.
Thakur PC; Miller-Ocuin JL; Nguyen K; Matsuda R; Singhi AD; Zeh HJ; Bahary N
J Transl Med; 2018 Jul; 16(1):190. PubMed ID: 29986726
[TBL] [Abstract][Full Text] [Related]
30. Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies.
Gray HJ; Bell-McGuinn K; Fleming GF; Cristea M; Xiong H; Sullivan D; Luo Y; McKee MD; Munasinghe W; Martin LP
Gynecol Oncol; 2018 Mar; 148(3):507-514. PubMed ID: 29352572
[TBL] [Abstract][Full Text] [Related]
31. Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.
Flaherty KT; Stevenson JP; Hahn SM; Redlinger M; O'Dwyer PJ
Cancer Chemother Pharmacol; 2003 Sep; 52(3):217-22. PubMed ID: 12811513
[TBL] [Abstract][Full Text] [Related]
32. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration.
Choi JH; Yoon JS; Won YW; Park BB; Lee YY
APMIS; 2012 Jul; 120(7):597-604. PubMed ID: 22716215
[TBL] [Abstract][Full Text] [Related]
33. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
[TBL] [Abstract][Full Text] [Related]
34. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
Kapuy O; Korcsmáros T
PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060
[TBL] [Abstract][Full Text] [Related]
35. Tolerability of gemcitabine and carboplatin doublet therapy in cats with carcinomas.
Martinez-Ruzafa I; Dominguez PA; Dervisis NG; Sarbu L; Newman RG; Cadile CD; Kitchell BE
J Vet Intern Med; 2009; 23(3):570-7. PubMed ID: 19298611
[TBL] [Abstract][Full Text] [Related]
36. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.
Rangwala R; Chang YC; Hu J; Algazy KM; Evans TL; Fecher LA; Schuchter LM; Torigian DA; Panosian JT; Troxel AB; Tan KS; Heitjan DF; DeMichele AM; Vaughn DJ; Redlinger M; Alavi A; Kaiser J; Pontiggia L; Davis LE; O'Dwyer PJ; Amaravadi RK
Autophagy; 2014 Aug; 10(8):1391-402. PubMed ID: 24991838
[TBL] [Abstract][Full Text] [Related]
37. Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice.
Vodicka P; Lim J; Williams DT; Kegel KB; Chase K; Park H; Marchionini D; Wilkinson S; Mead T; Birch H; Yates D; Lyons K; Dominguez C; Beconi M; Yue Z; Aronin N; DiFiglia M
J Huntingtons Dis; 2014; 3(2):159-74. PubMed ID: 25062859
[TBL] [Abstract][Full Text] [Related]
38. The combination of temsirolimus and chloroquine increases radiosensitivity in colorectal cancer cells.
Shiratori H; Kawai K; Hata K; Tanaka T; Nishikawa T; Otani K; Sasaki K; Kaneko M; Murono K; Emoto S; Sonoda H; Nozawa H
Oncol Rep; 2019 Jul; 42(1):377-385. PubMed ID: 31059051
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of autophagy with chloroquine is effective in melanoma.
Egger ME; Huang JS; Yin W; McMasters KM; McNally LR
J Surg Res; 2013 Sep; 184(1):274-81. PubMed ID: 23706562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
